These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31303777)

  • 1. Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo.
    Samaka RM; Basha MA; Menesy D
    Clin Cosmet Investig Dermatol; 2019; 12():469-480. PubMed ID: 31303777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris.
    Farag AGA; Samaka R; Elshafey EN; Shehata WA; El Sherbiny EG; Hammam MA
    Clin Cosmet Investig Dermatol; 2019; 12():497-508. PubMed ID: 31308720
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous JAK Expression in Vitiligo.
    Abdel Motaleb AA; Tawfik YM; El-Mokhtar MA; Elkady S; El-Gazzar AF; ElSayed SK; Awad SM
    J Cutan Med Surg; 2021; 25(2):157-162. PubMed ID: 33174479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo.
    Abdou AG; Maraee A; Yassien H; Sarhan M
    J Pathol Transl Med; 2018 Nov; 52(6):363-368. PubMed ID: 30347972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Janus Kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study.
    Nada HR; El Sharkawy DA; Elmasry MF; Rashed LA; Mamdouh S
    Arch Dermatol Res; 2018 Jan; 310(1):39-46. PubMed ID: 29127481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Janus kinase signaling pathway in acne lesions.
    Awad SM; Tawfik YM; El-Mokhtar MA; El-Gazzar AF; Abdel Motaleb AA
    Dermatol Ther; 2021 Jan; 34(1):e14563. PubMed ID: 33210790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature.
    Relke N; Gooderham M
    J Cutan Med Surg; 2019; 23(3):298-306. PubMed ID: 30902022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors.
    Cunningham KN; Rosmarin D
    Am J Clin Dermatol; 2023 Mar; 24(2):165-186. PubMed ID: 36715849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Association between
    Venkatesh V; Mendez DC; Rajashekar TS; Balakrishna S
    Indian J Dermatol; 2022; 67(2):133-137. PubMed ID: 36092187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of perforin and apoptosis stimulation fragment ligand (FasL)in active vitiligo.
    Hassan AS; Kohil MM; Sayed SSE; Mahmoud SB
    Arch Dermatol Res; 2021 Aug; 313(6):453-460. PubMed ID: 32785835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transducer and activator of transcription (STAT) 1 and STAT3 are expressed in the human ovary and have Janus kinase 1-independent functions in the COV434 human granulosa cell line.
    Frost ER; Ford EA; Peters AE; Reed NL; McLaughlin EA; Baker MA; Lovell-Badge R; Sutherland JM
    Reprod Fertil Dev; 2020 Aug; 32(12):1027-1039. PubMed ID: 32758351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
    Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.
    Qi F; Liu F; Gao L
    Front Immunol; 2021; 12():790125. PubMed ID: 34868078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of Janus kinase 1 and signal transducer and activator of transcription 3 and 6 in keratinocytes of canine atopic dermatitis.
    Ikai M; Murakami M; Kanei T; Asahina R; Iwata M; Kamishina H; Maeda S
    Vet Dermatol; 2023 Aug; 34(4):318-326. PubMed ID: 36929106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
    Fetter T; Smith P; Guel T; Braegelmann C; Bieber T; Wenzel J
    Front Immunol; 2020; 11():344. PubMed ID: 32194562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Janus kinase JAK1 maintains the ovarian reserve of primordial follicles in the mouse ovary.
    Sutherland JM; Frost ER; Ford EA; Peters AE; Reed NL; Seldon AN; Mihalas BP; Russel DL; Dunning KR; McLaughlin EA
    Mol Hum Reprod; 2018 Nov; 24(11):533-542. PubMed ID: 30247637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of JAK1 and STAT3 polymorphisms and their gene-gene interactions in nonspecific digestive disorder of rabbits.
    Fu L; Yang ZJ; Chen SY; Wang J; Lai SJ
    Gene; 2014 Jun; 543(1):8-14. PubMed ID: 24726550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
    Omura T; Yoshiyama M; Ishikura F; Kobayashi H; Takeuchi K; Beppu S; Yoshikawa J
    J Mol Cell Cardiol; 2001 Feb; 33(2):307-16. PubMed ID: 11162135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3.
    Sun J; Du Y; Zhang X; Wang Z; Lin Y; Song Q; Wang X; Guo J; Li S; Nan J; Yang J
    Invest New Drugs; 2020 Aug; 38(4):1003-1011. PubMed ID: 31612426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.